The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical ...

Global Nanopore Sequencing Market OverviewThe nanopore sequencing market is projected to grow at a CAGR of around 11% during the forecast period, driven by rising demand for real-time, portable DNA ...

The Global Targeted Sequencing Market is poised for growth due to rising demand for precise diagnostics in genetic disorders and cancer. Opportunities lie in leveraging AI for data analysis, enhancing ...

The Rajiv Gandhi Centre for Biotechnology becomes a national Next-Generation Sequencing hub, aiming to combat acute febrile illnesses through advanced metagenomic surveillance. A collaborative project ...

Accelerated sequencing technologies, AI-enabled analytics, newborn screening expansion, and government-backed genomic initiatives fuel rapid growth across North America, Europe, and ...

The global digestive health market is booming, valued at $51bn (€43bn) and projected to reach $68bn by 2030 with an 8.3% CAGR ...

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.

Cornell (NY, USA) researchers have found that a new DNA sequencing technology can be used to study how transposons move within and bind to the genome. Transposons play critical roles in immune ...

We call him the Evil Genius for a reason. Green helped define the early 2000s — an architect of the mixtape golden age who ...